Data / Form D filings / NexImmune, Inc.
NexImmune, Inc.: Form D filings
NexImmune, Inc., a biotechnology company in Gaithersburg, MD, filed 7 Form D notices with the SEC between 2012 and 2019. The latest, on February 22, 2019, reports $7.8 million sold of a $10 million offering to 42 investors.
Find out what NexImmune, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9119 Gaither Road, Gaithersburg, MD, 20877
- Phone
- (301) 825-9810
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1538210
The full lists. Form D filings in Maryland: 608 rows, $30.40, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 22, 2019 | New notice | $10,000,000 | $7,767,293 | $2,232,707 | 42 | Jan 8, 2019 | sec.gov |
| Feb 1, 2018 | New notice | $25,000,000 | $21,730,000 | $3,270,000 | 69 | Dec 28, 2017 | sec.gov |
| Feb 13, 2015 | New notice | $1,962,000 | $1,962,000 | $0 | 4 | Feb 3, 2015 | sec.gov |
| Jul 25, 2014 | New notice | $3,000,000 | $3,000,000 | $0 | 3 | Jul 10, 2014 | sec.gov |
| Dec 27, 2013 | New notice | $2,000,000 | $250,000 | $1,750,000 | 1 | Dec 23, 2013 | sec.gov |
| Feb 3, 2012 | New notice | $287,500 | $287,500 | $0 | 11 | Nov 15, 2011 | sec.gov |
| Feb 3, 2012 | New notice | $1,000 | $1,000 | $0 | 9 | Jun 7, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Bing Yao | Director | |
| Paul D'Angio | Director | |
| Scott Carmer | Executive Officer, Director | |
| Timothy Bertram | Director | |
| Alain Cappeluti | Executive Officer | |
| Alan Roemer | Director | |
| Robert Spiegel | Director | |
| Tony Yao | Director |
Other biotechnology companies in Maryland that filed recently
- BlueHealer Inc. $1 · Nov 4, 2026
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
- Uvantis Therapeutics, Inc. $100,000 · Sep 23, 2026
- Gliknik Inc $15 million · Sep 17, 2026
- Georgiamune, Inc. $92.7 million · Aug 17, 2026
Every Form D from the week of Feb 18, 2019 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what NexImmune, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.